Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

    Stroke Date published:

  • Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease

    Circulation Date published:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    The Lancet Date published:

  • Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

    Kidney International Date published:

  • Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial

    Cardiovascular Research Date published:

  • Quality of Life in Caregivers of Patients Randomized to Standard- Versus Extended-Hours Hemodialysis

    Kidney International Reports Date published:

  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis

    The Lancet Oncology Date published:

  • Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial

    American Heart Journal Date published:

  • Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

    Nephrology Dialysis Transplantation Date published:

  • Hemodialysis Use and Practice Patterns: An International Survey Study

    American Journal of Kidney Diseases Date published:

  • Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program

    Endocrinology, Diabetes & Metabolism Date published:

  • Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial

    Diabetes, Obesity and Metabolism Date published:

  • The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals

    Kidney International Date published:

  • An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials

    International Journal of Cardiology Date published:

  • Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

    Clinical Journal of the American Society of Nephrology Date published:

  • Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program

    ESC Heart Failure Date published: